Atorvastatin API Market Overview, COVID-19 Impact and Segmental Analysis By 2027

6 day(s) ago

Market Outlook

The global atorvastatin API market is predicted to enjoy 3.34% CAGR from 2018 to 2023 (forecast period) to touch a size of USD 425 million. High prevalence of cardiovascular diseases is expected to be the primary driver of the market during the forecast period. Rising cases of dyslipidemia in China can open up new avenues of growth for the market. High triglyceride levels and LDL cholesterol caused by obesity and sedentary lifestyles of patients can lend a helping hand to the atorvastatin API market.

High volume of kidney disorders combined with high dosage of the drug in the elderly populace to control their cholesterol levels can bode well for the market. Approval of mass production of drugs from federal agencies can drive the atorvastatin API market growth. Recently, the U.S. FDA granted license to Morepen Laboratories for the production of atorvastatin calcium for export to the U.S. Strict regulation outlined by federal agencies as well as compliance for switching to green methods of production can bode well for the market. But adverse effects of the drug can hamper the market growth.

also read @

Competitive Analysis

Major industry participants in the global atorvastatin API market include Ind-Swift Labs Ltd, Teva Pharmaceutical Industries Ltd, Zhejiang Hisun Pharmaceutical Co Ltd, Anuh Pharma Ltd, Morepen Laboratories Ltd, Jubilant Life Sciences Ltd, Cadila Pharmaceuticals, Centrient Pharmaceuticals, Sun Pharmaceutical Industries Ltd, and Dr. Reddy’s Laboratories Ltd. Scaling of efforts to expedite research and development for mass production of the drug as well as compliance to latest standards are strategies employed by players to gain leverage over the competition.

Segmentation Analysis

Atorvastatin API Market Overview is segmented by application.

By application, it is segmented into dyslipidemia, hypertriglyceridemia, hypercholesterolemia, and others. The hypercholesterolemia segment is bound to generate close to USD 210.7 million by 2023. High prevalence of the disease can ensure the segment to display a strong CAGR of 4.09% during the forecast period. On the other hand, dyslipidemia segment is bound to have a high growth potential till 2023.

Regional Analysis

The Middle East & Africa, North America, Latin America, Asia Pacific (APAC), and Europe are regions taken into consideration in the compilation of the global atorvastatin API market report.

North America accounted for 40.64% market share in 2017 due to the U.S. being one of the biggest contributors of the market. It can register 3.10% CAGR during the forecast period to gain high dividends for the global atorvastatin API market.

The APAC region is expected to exhibit one of the strongest growth rates during the forecast period due to large approval of drugs in the region. Contract manufacturing and outsourcing companies which take up research and development of large pharmaceutical companies have widened the potential of the market. China, in particular, is touted to exhibit 5.86% CAGR during the forecast period.

The Europe atorvastatin API market is touted to exceed a valuation of USD 131 million by 2023. Rising cases of dyslipidemia and hypercholesterolemia are primarily fueling the market demand. France and the U.K. are major contributors in the region. Expansions of production facilities to create generic versions of the Lipitor drug is likely to culminate in higher bottomline margins for players. Recently, DSP Sinochem Pharmaceuticals has launched Rosuvastatin for its clients as well as producing them in large quantities for third-party customers.

Get access to full summary @

related reports

Global Mammography Market - Forecast to 2027

Osteoporosis Drugs Market Report – Forecast 2027

Global Anesthesia Drugs Market - Global Forecast To 2027

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


Submit your ad?

Submit your website for more traffic!

Submit URL

Recent submissions

Cesspool Service Long Island

Business Address: 85 Sweet Hollow Rd Huntington, NY 11743 Business Phone: 631-910-6662 Business Email: Description: Cesspool Service Long Island specializes in septic tank ..

Search Online Digital Marketing & SEO Company in UK

SJ Business Marketing is the best Digital Marketing & SEO Company in India. We offer the best services for your business get your own business website and get online business.

SEO Marketing Services for Dermatology | MediBrandox

Medibrandox provides local SEO marketing services for dermatology practice and helps to expand its services in the best possible ways. Contact us for dermatology local SEO and its prerequisites. Local ..

Search Online Website Development & designing Company in USA

SJ Business Marketing is the best Website Design & Web Development Company in India. We offer the best services for your business get your own business website and get online business.

Website Design & Web Development Company

Our specialty lies in MS, Open source and WordPress website development. We are among best WordPress development company. No.1 Web Development Company Gurugram, Noida, Delhi NCR, India and USA with best ..

© 2020 Imprint, All rights reserved.